Showing results (161-170 of 980) with videos related to

Sort By:
Pageof 98
Cardiovascular Therapeutics|March 19, 2026
NHANES-Derived Machine Learning Model for Early Identification of Frailty Risk in CKM: Optimizing Resource Allocation Through Predictive AnalyticsWenlong Ding, Caoyang Fang, Fachao Shi, et al.
Cardiovascular Therapeutics|April 20, 2026
Association Between Albumin-Corrected Anion Gap and Mortality in ICU Patients With Acute Heart Failure: A MIMIC-IV Cohort StudyHuijuan Pu, Guoping Zhao, Yumin Wang, et al.
Cardiovascular Therapeutics|April 1, 2026
Effect of Statin Use on Mortality in Individuals With Cardiovascular-Kidney-Metabolic Syndrome: A Retrospective Propensity Score-Matched Cohort StudyCheng Yuan, Yuguo Ge, Wenqi Ge, et al.
Cardiovascular Therapeutics|February 27, 2026
The Combined Double-Orifice and Single-Patch Technique for Partial Atrioventricular Septal Defect in Adults: A Novel StrategyHua-Jie Zheng, Rui-Han Xiao, Mao-Ting Ye, et al.
Cardiovascular Therapeutics|January 1, 2017
Comparison of early- and new-generation drug-eluting stent implantations for ostial right coronary artery lesionsYusuke Watanabe, Kensuke Takagi, Toru Naganuma, et al.
Cardiovascular Therapeutics|November 4, 2016
Salidroside protects against homocysteine-induced injury in human umbilical vein endothelial cells via the regulation of endoplasmic reticulum stressLin Zhu, Fang Jia, Jiang Wei, et al.
Cardiovascular Therapeutics|January 6, 2017
Epoetin beta pegol ameliorates flow-mediated dilation with improving endothelial nitric oxide synthase coupling state in nonobese diabetic ratsKenichi Serizawa, Kenji Yogo, Yoshihito Tashiro, et al.
Cardiovascular Therapeutics|April 23, 2014
Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: meta-analysis of randomized clinical trials with 55,141 participantsShiying Wu, Ingrid Hopper, Marina Skiba, et al.
Cardiovascular Therapeutics|March 13, 2014
Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemiaAnastazia Kei, Constantinos Tellis, Evangelos Liberopoulos, et al.
Cardiovascular Therapeutics|May 20, 2008
Viability of developing CETP inhibitorsCesare R Sirtori, Giuliana Mombelli
Pageof 98